WHO-GMP sourced EU-GMP partners ISO 9001:2015 49+ export markets Since 2003

Pharmaceutical Exporter from India to UAE.

The UAE is the anchor of our Gulf operation. Our Dubai commercial desk works with licensed importers, hospital groups and government tender teams in the UAE, and M Care Exports ships by air and by sea, including into Dubai and Jebel Ali. Registration is held by a UAE-licensed local agent, not by us, and we supply the product and the dossier documentation behind it.

WhatsApp a UAE enquiry → Start a written enquiry
Jump to: Anti-infectives Oncology Cardiovascular Diabetes & endocrine CNS & neurology General & OTC All 18 →
WHO-GMP sourcing CDSCO licensed exporter EU-GMP capable partners ISO 9001:2015 SGS GDP Certified Pharmexcil RCMC FIEO Member Cold-chain validated CTD / eCTD ready
Regulatory environment

The Emirati regulatory stack, decoded.

The Emirates Drug Establishment (EDE) now runs the federal drug register, having taken over registration and marketing authorisation from MOHAP on 29 December 2025 under Federal Decree-Law 38 of 2024. Every imported SKU carries a federal drug registration, filed electronically through the EDE portal (ede.gov.ae) in eCTD format via a UAE-based local authorised representative. Dossiers follow the ICH CTD and eCTD structure, with Module 1 written to EDE specifications and a parallel GCC Module 1 where a joint-market dossier is filed. The EDE's service card for issuing a marketing authorisation states a service completion duration of 45 working days; dossier preparation and answering the EDE's questions add to the calendar time.

Health-facility licensing sits at emirate level: the Dubai Health Authority (DHA) is the health authority for Dubai, and the Department of Health Abu Dhabi (DoH) regulates healthcare in Abu Dhabi. Sharjah has its own Sharjah Health Authority. Controlled substances need an import authorisation permit for narcotic drugs and psychotropic substances, which the EDE lists among its services. We confirm the labelling and patient-information language requirements with your UAE local agent before artwork is printed.

The Gulf Health Council pathway deserves careful attention. The GHC runs a central registration procedure, a unified system for registering medical products across the GCC states, under which one dossier is reviewed centrally. We prepare GCC-CTD dossier documentation where the molecule's commercial life justifies it; single-market EDE filings still make sense for niche indications.

Call & WhatsApp the Mumbai desk: +91 70156 05768 · [email protected] · Mon–Sat 09:30–18:30 IST

Reference table

Key UAE pharmaceutical regulators at a glance.

Hyperlinked to the official portal for each authority. Use this as a quick-reference when scoping a UAE registration project. Last reviewed: November 2026.

Regulator Full name Covers Portal Typical timeline
EDEEmirates Drug Establishment (took over from MOHAP, 29 Dec 2025)Federal drug and medical-product register, all emiratesede.gov.ae45 working days (EDE service card)
MOHAPMinistry of Health and PreventionFederal health policymohap.gov.aeN/A
DHADubai Health AuthorityDubai health authoritydha.gov.aeFacility-dependent
DoH Abu DhabiDepartment of Health, Abu DhabiAbu Dhabi facilities, SEHA network, Burjeeldoh.gov.aeFacility-dependent
GHCGulf Health Council (central registration)UAE + KSA + Kuwait + Oman + Qatar + Bahrainghc.saNo published timeline
CDSCOCentral Drugs Standard Control Organisation (India)Indian side: joins the WHO-GMP inspection and runs the ONDLS application portal; the state drug regulator issues the WHO-GMP certificate and CoPPcdsco.gov.inVaries by state and product
Route, step by step

Registration and tender route for the UAE, in the order you meet it.

Seven steps from registrability to first shipment, taken only from the published UAE EDE guide, which does not cover tender submission.

  1. Check the product is registrable. Before I shortlist a product, I ask whether the manufacturer holds Zone IVa stability data at 30°C / 65% RH, the GCC long-term condition. A manufacturer with only EU-condition data at 25°C / 60% RH will usually need extra studies. In the guide
  2. Appoint a UAE-licensed local agent. Registration is never held on the Indian side. I appoint a UAE-licensed pharmaceutical establishment, such as a medical warehouse or marketing office, to file. Foreign companies cannot hold UAE pharmaceutical facility licences or import permits. In the guide
  3. Plan for two importers per product. Under Article 22 of Federal Decree-Law No. 38 of 2024, the marketing authorisation holder must appoint at least two licensed importers and one or more distributors. I structure new agency agreements with this in mind. In the guide
  4. Collect the Indian-side documents. I ask M Care Exports for the supply side of the file: CTD documentation, manufacturer certificates, stability data and samples, from WHO-GMP manufacturing. M Care works alongside my UAE local agent, and the agent files. In the guide
  5. Have the agent file the dossier. My agent files the eCTD through the Emirates Drug Establishment digital portal, logging in via UAE PASS. The technical dossier is in English. Labelling and patient information need Arabic. For a generic, bioequivalence with the reference product must be demonstrated. In the guide
  6. Budget the fees and the wait. The inherited official tariff is AED 100 for the application and AED 7,000 for registration. The EDE's service card gives 45 working days to issue a marketing authorisation. Dossier preparation and answering the EDE's questions add to the calendar time, and I confirm the current tariff on the portal. In the guide
  7. Get the import permit, then ship. Marketing approval must come first. Then an initial import permit is filed before shipping, then a shipment clearance request once the air waybill or bill of lading exists. Permits are issued per shipment, and I confirm the permit validity on the EDE portal. In the guide
What we do for Emirati customers

Six capabilities, pre-assembled.

EDE dossier documentation

In-house regulatory team prepares the CTD and eCTD dossier documentation that your UAE local agent files through the EDE portal. Variations, renewals and PSURs tracked on a shared calendar with the importer of record.

Bonded stock in JAFZA, DAFZA and SAIF Zone

Free-zone warehousing with temperature-controlled storage and a dedicated 2-8 degree cold room. Stock is held against customer call-off and imported into the mainland only on release from the free zone.

Hospital group pharmacy channel

Mediclinic Middle East, NMC Healthcare, Aster DM, Burjeel Holdings, Emirates Hospital Group, Thumbay and VPS Healthcare are among the private hospital groups operating in the UAE. M Care Exports quotes into hospital pharmacy channels through licensed importers, with batch-level traceability and CoA and CoO on every dispatch.

SEHA and Dubai Health tender response

Full technical and commercial pack for SEHA (Abu Dhabi Health Services Company) and the consolidated Dubai Health entity. We keep stability data current and coordinate with a UAE-licensed local partner through our Dubai desk.

GHC joint registration

Gulf Health Council central-registration dossiers are reviewed centrally for the GCC states. We prepare the GCC-CTD dossier documentation for the applicant.

Arabic bilingual artwork

EDE-compliant Arabic typesetting with native-speaker medical review, outer-carton bilingual layout, patient information leaflet translation, and artwork proof approval coordinated with your commercial team before any print run.

IV sets & hospital consumables →

Beyond medicines, we source IV infusion sets, burette and transfusion sets and single-use consumables from ISO 13485 manufacturers, with the device documentation your UAE agent needs for EDE registration or a hospital tender.

The logistics spine

From Mumbai to Jebel Ali and Dubai.

Air freight: BOM-DXB is the direct air route from Mumbai to Dubai. Customs clearance in Dubai is handled by our nominated freight agent through Dubai Customs' electronic declaration system. DEL-DXB and BLR-DXB routes back up the Mumbai gateway for north-India and south-India sourced product.

Sea freight: containers move from Nhava Sheva (JNPT) to Jebel Ali. Less-than-container-load consolidation is available for smaller orders.

Secondary entry points: Abu Dhabi International (AUH) and Khalifa Port for capital-emirate deliveries, and Sharjah International (SHJ) for northern-emirate distribution. Cold-chain consignments use validated temperature-controlled containers for 2-8 degrees and 15-25 degrees, with temperature loggers. Bonded stock at JAFZA lets customers shorten lead time on fast-moving lines.

Payment terms: documentary LC at sight for first-time customers; terms for repeat customers, including open account, are agreed case by case. Insurance at Institute Cargo Clauses A, covering door-to-door.

Formulary focus

What we ship most into the UAE.

Oncology biosimilars and supportive-care injectables lead the volume. The lines include trastuzumab, rituximab and bevacizumab biosimilars, plus granisetron and pegfilgrastim support. Targeted haematology agents including ruxolitinib for myelofibrosis are available for haemato-oncology programmes. See the UAE oncology supply detail for the hospital pathway.

Cardiometabolic is the second pillar. The lines include statins, SGLT2 inhibitors including dapagliflozin + metformin fixed-dose, DPP-4 inhibitors and ARBs. Anti-infectives follow: broad-spectrum cephalosporins, carbapenems and antifungals.

Critical-care injectables (noradrenaline, vasopressin, propofol, calcium gluconate), ophthalmology, dermatology and gastroenterology complete the hospital-formulary roster. UAE lines ship with labelling agreed with your UAE local agent and CoA-per-batch documentation.

A Dubai private hospital group consolidated its oncology cold-chain supply under M Care in Q2 2024. We positioned a 60-day buffer of trastuzumab biosimilar and pegfilgrastim at JAFZA, wired the group's pharmacy PO system into our Mumbai dispatch platform, and cut the group's cold-chain stockout incidents from four in the prior twelve months to zero across the first 14 months of the arrangement. Temperature-excursion reports dropped from an industry-typical 3% of consignments to under 0.4%. Total consignment count across the period: 47.

Case reference United Arab Emirates · Illustrative operational case, 2024-25
Working with an Indian supplier from the UAE

Why Indian pharma, why M Care, and what you actually get.

Indian manufacturing offers WHO-GMP capacity at scale, a deep API base and ICH-aligned stability programmes.

The harder question is which Indian supplier. Our Mumbai head office is our regulatory engine room: dossier writing, CMC review, stability coordination and pharmacovigilance happen there. Our Dubai commercial desk is our face to the Emirati buyer: account management, tender coordination, in-country bonded stock oversight and direct contact with your procurement team. Our London desk handles the European-origin audit trail for customers who want a UK-QP verification layer on top of the Indian certification.

Three specifics that distinguish the working relationship. First, a single named account manager, not a rotating pool. Your procurement head has one mobile number and one email, and that person owns the file from RFQ through re-order. Second, GCC joint-market dossiers: because the Gulf Health Council runs a central registration procedure, your UAE registration can be planned from day one as the anchor of a broader GCC portfolio. Third, CTD readiness: our dossiers are built eCTD-compliant from the first submission, so EDE variations, GHC extensions and EU or UK filings later pull from the same source pack without the usual retrofit cost.

What you will not get from M Care: padded lead times, price ratchets on repeat orders, or the mysterious documentation gaps that show up three weeks before a tender submission deadline. What you will get: WHO-GMP-sourced product with audit-ready paperwork, a Dubai team that speaks your weekend and your working hours, and a Mumbai engine room that treats an Emirati purchase order with the same seriousness as a London teaching-hospital contract.

Frequently asked

UAE pharmaceutical import: common questions.

Which regulator registers pharmaceutical products in the UAE?

The Emirates Drug Establishment (EDE) is the UAE federal drug and medical-product regulator, having taken over registration and marketing authorisation from MOHAP on 29 December 2025 under Federal Decree-Law 38 of 2024. Every imported finished SKU carries a federal drug registration filed through the EDE portal (ede.gov.ae), submitted by a UAE Local Authorised Representative. The Dubai Health Authority (DHA) is the health authority for Dubai and DoH Abu Dhabi regulates healthcare in the capital. Sharjah has its own Sharjah Health Authority. The EDE also issues the import authorisation permit for narcotic drugs and psychotropic substances.

How long does EDE drug registration typically take?

The EDE's service card for issuing a marketing authorisation states a service completion duration of 45 working days. Dossier preparation, the EDE's questions and pricing add to the calendar time, so plan the launch with your importer. The Gulf Health Council's central procedure has no published review timeline.

Is Arabic labelling mandatory?

We confirm the labelling and patient-information language requirements for each product with your UAE local agent. We commission the Arabic typesetting, run it past a native-speaker medical reviewer, and agree the artwork with you before any print run.

Can M Care bid on SEHA and Dubai Health tenders?

Yes, through our Dubai commercial desk, working with a UAE-licensed local partner. Each tender document sets its own requirements, so we read it with the buyer before bidding.

What cold-chain guarantees do you offer on BOM-DXB shipments?

Validated temperature-controlled containers for 2-8 degrees and 15-25 degrees, continuous temperature logging, and a landing-side cool-dolly handover. Any excursion outside the validated range is investigated. Insurance on Institute Cargo Clauses A, door-to-door.

Do you supply controlled substances to the UAE?

Controlled medicines need an import authorisation for narcotic drugs and psychotropic substances from the EDE, and the importing facility must hold a valid EDE licence. Send us the molecule and quantity, and we confirm what can be supplied and prepare the documentation your importer needs.

How is payment typically structured?

First-time customers: part advance by TT with the balance against the scanned Bill of Lading, or a sight LC through a first-tier UAE bank. Open-account terms for repeat customers are agreed case by case, depending on order history and credit-insurance cover.

Indian pharmaceutical supply built for the UAE

Why buyers choose M Care for the India → the UAE corridor.

EDE fluency

Dossiers built to the format the EDE reviews, not a generic CTD dump. We know which modules get scrutinised first, which stability data triggers queries, and which legalisation chain the submission needs to clear on the first pass.

Logistics you can schedule around

BOM → DXB direct air for time-critical orders, and Jebel Ali for high-volume ambient sea freight. Cold-chain SKUs run on validated containers with continuous temperature logging. Consolidation at origin so you order by molecule, not by MOQ.

Commercial discipline, one point of contact

USD invoicing with clear FX-clause language, LC / TT / open-account progression as the relationship proves out, 18 therapeutic areas on one PO, and one named account manager from enquiry through clearance in the UAE.

Shop by therapeutic area

Top categories we ship to the UAE

Send us your Emirati brief

Molecule, volume, target buyer. One working day to a quote.

Your enquiry goes directly to the account manager responsible for the UAE. No call-centre hops, no generic autoresponders, just the answer your procurement file needs.

Start a UAE enquiry → Back to all markets

Buying for repeat supply? Open a trade account for a named account manager and priced quotes.